These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Genetic counseling in myotonia and muscular dystrophy]. Becker PE Internist (Berl); 1978 Aug; 19(8):475-81. PubMed ID: 357337 [No Abstract] [Full Text] [Related]
3. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels. Muir WA; Knoke J; Martin A; Vignos P; McErlean A Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600 [TBL] [Abstract][Full Text] [Related]
4. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection. Passos MR; Gonzalez CH; Zatz M Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856 [TBL] [Abstract][Full Text] [Related]
6. [Experience with medico-genetic counseling of the families of patients with Duchenne muscular dystrophy]. Krasil'nikov VV; Lazebnik TA; Shilov LA Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):338-40. PubMed ID: 3577524 [TBL] [Abstract][Full Text] [Related]
7. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy. Zatz M; Passos MR; Bortolini ER Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115 [No Abstract] [Full Text] [Related]
9. Genetic counselling in neuromuscular diseases in Western Australia. Hurse PV; Kakulas BA Proc Aust Assoc Neurol; 1974; 11():145-53. PubMed ID: 4469625 [No Abstract] [Full Text] [Related]
10. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling. Bushby K; Goodship J; Haggerty D; Heald A; Walls T Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338 [No Abstract] [Full Text] [Related]
11. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy. Skinner R; Emery AE; Anderson AJ; Foxall C J Med Genet; 1975 Jun; 12(2):131-4. PubMed ID: 1142377 [No Abstract] [Full Text] [Related]
12. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458 [TBL] [Abstract][Full Text] [Related]
14. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)]. Rotthauwe HW; Kowalewski S Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596 [No Abstract] [Full Text] [Related]
15. The genetics of muscular dystrophies. Harper PS Prog Med Genet; 1985; 6():53-90. PubMed ID: 3915367 [No Abstract] [Full Text] [Related]
16. Diagnosis, carrier detection, and genetic counseling in the muscular dystrophies. Zatz M Pediatr Clin North Am; 1978 Aug; 25(3):557-73. PubMed ID: 693082 [No Abstract] [Full Text] [Related]
17. Estimate of the intrafamilial correlation for serum creatine kinase and pyruvate kinase in females at risk for Duchenne and Becker muscular dystrophies. Rabbi-Bortolini E; Dal Colletto GM; Passos-Bueno MR; Vainzof M; Rapaport D; Zatz M Hum Hered; 1991; 41(6):370-8. PubMed ID: 1797630 [TBL] [Abstract][Full Text] [Related]
19. Carrier detection and prenatal diagnosis of Duchenne/Becker muscular dystrophy (D/BMD) by DNA-analysis. Bakker E; Bonten EJ; den Dunnen JT; Veenema H; Grootscholten PM; van Ommen GJ; Pearson PL Prog Clin Biol Res; 1989; 306():51-67. PubMed ID: 2662213 [No Abstract] [Full Text] [Related]
20. Somatic mosaicism at the Duchenne locus. Lebo RV; Olney RK; Golbus MS Am J Med Genet; 1990 Oct; 37(2):187-90. PubMed ID: 1978985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]